107 related articles for article (PubMed ID: 1614193)
1. [Clinical sequelae of hyperinsulinemia in diabetes mellitus].
Standl E
Klin Wochenschr; 1992; 69 Suppl 29():63-7. PubMed ID: 1614193
[TBL] [Abstract][Full Text] [Related]
2. [Insulin level--a parameter for risk of arteriosclerosis?].
Standl E
Versicherungsmedizin; 1991 Apr; 43(2):48-52. PubMed ID: 2058079
[TBL] [Abstract][Full Text] [Related]
3. [Insulin resistance and cardiovascular complications].
Janka HU
Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
[TBL] [Abstract][Full Text] [Related]
4. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
Bretzel RG
Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
[TBL] [Abstract][Full Text] [Related]
5. [Coronary heart disease and insulin concentration in type II diabetic patients--results of a diabetes intervention study].
Lindner J; Schmechel H; Hanefeld M; Schwanebeck U; Bauch K
Z Gesamte Inn Med; 1992 Jun; 47(6):246-50. PubMed ID: 1642023
[TBL] [Abstract][Full Text] [Related]
6. Is insulin resistance atherogenic? A review of the evidence.
Ferrannini E; Iozzo P
Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
8. Small artery remodeling in diabetes mellitus.
Rizzoni D; Rosei EA
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):587-92. PubMed ID: 19481431
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?
Jadhav S; Petrie J; Ferrell W; Cobbe S; Sattar N
Heart; 2004 Dec; 90(12):1379-83. PubMed ID: 15547007
[TBL] [Abstract][Full Text] [Related]
12. [Arterial hypertension and diabetes].
González Maqueda I
Rev Esp Cardiol; 1997; 50 Suppl 4():33-48. PubMed ID: 9411586
[TBL] [Abstract][Full Text] [Related]
13. Role of insulin resistance and hyperglycemia in the development of atherosclerosis.
Bansilal S; Farkouh ME; Fuster V
Am J Cardiol; 2007 Feb; 99(4A):6B-14B. PubMed ID: 17307054
[TBL] [Abstract][Full Text] [Related]
14. Hyperinsulinemia and atherosclerosis.
Standl E
Clin Invest Med; 1995 Aug; 18(4):261-6. PubMed ID: 8549011
[TBL] [Abstract][Full Text] [Related]
15. Hyperinsulinemia in subjects with and without coronary artery disease: a preliminary study from North India.
Mahajan R; Daga MK; Bhattacharjee J
Indian Heart J; 2002; 54(6):687-91. PubMed ID: 12674181
[TBL] [Abstract][Full Text] [Related]
16. Vascular growth factors and the development of macrovascular disease in diabetes mellitus.
Koschinsky T; Bünting CE; Rütter R; Gries FA
Diabete Metab; 1987 Jul; 13(3 Pt 2):318-25. PubMed ID: 3308559
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease.
Winkelmann BR; Boehm BO; Nauck M; Kleist P; März W; Verho NK; Ranjith N; Kneissl G
Curr Med Res Opin; 2001; 17(2):132-41. PubMed ID: 11759183
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and the endothelium.
Hsueh WA; Lyon CJ; Quiñones MJ
Am J Med; 2004 Jul; 117(2):109-17. PubMed ID: 15234647
[TBL] [Abstract][Full Text] [Related]
19. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
Fonseca VA
Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
[TBL] [Abstract][Full Text] [Related]
20. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
